Literature DB >> 8558510

Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.

R B Greenwald1, C W Gilbert, A Pendri, C D Conover, J Xia, A Martinez.   

Abstract

Water soluble 2'-taxol poly(ethylene glycol) (PEG) esters have been synthesized and shown to function in vitro as prodrugs. However, in vivo experiments clearly establish that in order for these prodrugs to behave in a predictable fashion, the molecular weight of PEG must be of such magnitude so as to maintain a t1/2(circulation) > t1/2(hydrolysis). When PEG derivatives of molecular weight approximately 40 kDa were employed with paclitaxel, ca. 4% by weight of paclitaxel was carried by the water soluble prodrug form, and equivalent in vivo toxicity and increased life expectancy in the P388-treated mouse was observed. An effective method for prescreening prodrugs was found to be the acute murine lethality, which reflects the equivalency of the solubilized transport form and the native drug.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558510     DOI: 10.1021/jm950475e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

Review 1.  Camptothecin delivery methods.

Authors:  A Hatefi; B Amsden
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.

Authors:  Jiong Zou; Fuwu Zhang; Shiyi Zhang; Stephanie F Pollack; Mahmoud Elsabahy; Jingwei Fan; Karen L Wooley
Journal:  Adv Healthc Mater       Date:  2013-08-30       Impact factor: 9.933

Review 3.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.

Authors:  Tian Luo; Johannes Magnusson; Véronique Préat; Raphael Frédérick; Cameron Alexander; Cynthia Bosquillon; Rita Vanbever
Journal:  Pharm Res       Date:  2016-03-16       Impact factor: 4.200

Review 5.  Progress in the development of alternative pharmaceutical formulations of taxanes.

Authors:  B Nuijen; M Bouma; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

6.  Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy.

Authors:  Aniruddha Roy; Sourav Chandra; Swapna Mamilapally; Pramod Upadhyay; Sangeeta Bhaskar
Journal:  Pharm Res       Date:  2012-05-01       Impact factor: 4.200

7.  Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation.

Authors:  Raghavendra S Navath; Bing Wang; Sujatha Kannan; Roberto Romero; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2009-11-05       Impact factor: 9.776

8.  Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine.

Authors:  Minh Khanh Nguyen; Eben Alsberg
Journal:  Prog Polym Sci       Date:  2014-07       Impact factor: 29.190

Review 9.  From stealthy polymersomes and filomicelles to "self" Peptide-nanoparticles for cancer therapy.

Authors:  Núria Sancho Oltra; Praful Nair; Dennis E Discher
Journal:  Annu Rev Chem Biomol Eng       Date:  2014       Impact factor: 11.059

Review 10.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.